Status
Operational
Law Signed:
2016
QUALIFYING CONDITIONS
- ALS (Lou Gehrig’s disease)
- Anxiety disorders
- Autism
- Cancer, including remission therapy
- Crohn’s disease
- Damage to the nervous tissue of the central nervous system (brain-spinal cord) with objective neurological indication of intractable spasticity and other associated neuropathies
- Dyskinetic/spastic movement disorders
- Epilepsy
- Glaucoma
- HIV/AIDS
- Huntington’s disease
- Inflammatory bowel disease
- Intractable seizures
- Intractable spasticity
- Multiple Sclerosis
- Opioid dependency
- Neurodegenerative disorders
- Neuropathies
- Parkinson’s disease
- Post-traumatic stress disorder
- Sickle cell anemia
- Severe chronic or intractable pain
- Terminal illness (defined as 12 months or fewer to live)
- Tourette syndrome
- Other conditions that are recommended by the advisory board and approved by the secretary
PATIENT POSSESSION LIMITS
90 day supply — As initially enacted, only cannabis-infused pills, oils, topical ointments, tinctures or liquids were allowed. On April 16, 2018, the state Health Secretary approved an advisory board recommendation to permit dispensaries to also begin providing herbal cannabis. Under the rule change, patients are permitted to vaporize herbal cannabis, but are still prohibited under the law from smoking.
HOME CULTIVATION
No
STATE-LICENSED DISPENSARIES
Yes, up to 25 growers and processors, and as many as 50 dispensaries, which could each operate three locations.
STATE-LICENSED DISPENSARIES OPERATIONAL
Yes
CAREGIVERS
Yes
ESTIMATED NUMBER OF REGISTERED PATIENTS
- 297,317
- Source: Pennsylvania Department of Health, as of March 2020
EMPLOYMENT PROTECTIONS FOR QUALIFYING PATIENTS
- Yes
- Details
RECIPROCITY
Under Section 2106 of the law, it is not a violation of state law “if a parent or guardian of a minor under 18 years of age lawfully obtains medical marijuana from another state, territory of the United States or any other country to be administered to the minor.”